The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.

Autor: Van den Eynde V; PsychoTropical Research, QLD, Australia., Abdelmoemin WR; Department of Psychiatry, University of Toronto, Toronto, ON, Canada., Abraham MM; Neurawell Therapeutics, Boca Raton, FL, USA., Amsterdam JD; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Anderson IM; Department of Psychiatry, University of Manchester, Manchester, UK., Andrade C; Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India., Baker GB; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada., Beekman ATF; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands., Berk M; Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia., Birkenhäger TK; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands., Blackwell BB; Department of Psychiatry, University of Wisconsin, Milwaukee, WI, USA., Blier P; Departments of Psychiatry and Cellular & Molecular Medicine, University of Ottawa, Ottawa, ON, Canada., Blom MBJ; Parnassia Groep, The Hague, The Netherlands., Bodkin AJ; Department of Psychiatry, Harvard Medical School, Boston, MA, USA., Cattaneo CI; Brain Stimulation Italia, Cavaglietto, Italy., Dantz B; Department of Psychiatry and Behavioral Sciences, Rush Medical College, Chicago, IL, USA., Davidson J; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA., Dunlop BW; Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA., Estévez RF; College of Medicine, University of Central Florida, Orlando, FL, USA., Feinberg SS; Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, NY, USA., Finberg JPM; Department of Molecular Pharmacology, Technion-Israel Institute of Technology, Haifa, Israel., Fochtmann LJ; Department of Psychiatry, Department of Pharmacological Sciences, and Biomedical Informatics, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USA., Gotlib D; Unaffiliated, Toronto, ON, Canada., Holt A; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada., Insel TR; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA., Larsen JK; Department of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark., Mago R; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Menkes DB; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Meyer JM; Department of Psychiatry, UC San Diego School of Medicine, San Diego, CA, USA., Nutt DJ; Department of Brain Sciences, Imperial College, London, UK., Parker G; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia., Rego MD; Yale Institute for Global Health, Yale School of Medicine, New Haven, CT, USA., Richelson E; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA., Ruhé HG; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands., Sáiz-Ruiz J; Department of Psychiatry, Alcala University, Madrid, Spain., Stahl SM; Department of Psychiatry and Neuroscience, University of California, Riverside, Riverside, CA, USA., Steele T; Department of Psychiatry and Behavioral Sciences, University of South Carolina, Columbia, SC, USA., Thase ME; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ulrich S; Aristo Pharma GmbH, Berlin, Germany., van Balkom AJLM; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands., Vieta E; Department of Psychiatry and Psychology, University of Barcelona Hospital Clinic, Barcelona, Spain., Whyte I; Department of Clinical Toxicology and Pharmacology, University of Newcastle, Callaghan, NSW, Australia., Young AH; Department of Psychological Medicine, King's College London, London, UK., Gillman PK; PsychoTropical Research, QLD, Australia.

Publikováno v: CNS spectrums [CNS Spectr] 2023 Aug; Vol. 28 (4), pp. 427-440. Date of Electronic Publication: 2022 Jul 15.

A novel stability-indicating chromatographic quantification of the antiparkinsonian drug safinamide in its pharmaceutical formulation employing HPTLC densitometry and ion-pair HPLC–DAD.

Autor: Ibrahim, Engy A.¹ (AUTHOR), Saad, Samah S.¹ (AUTHOR), Hegazy, Maha A.² (AUTHOR), Abdel Fattah, Laila E.¹ (AUTHOR), Marzouk, Hoda M.³ (AUTHOR) hodaallah.marzouk@pharma.cu.edu.eg

Publikováno v: BMC Chemistry. 11/1/2024, Vol. 18 Issue 1, p1-16. 16p.

Pharmacological intervention of behavioural traits and brain histopathology of prenatal valproic acid-induced mouse model of autism.

Autor: Neelotpol, Sharmind¹ (AUTHOR) sharmind@bracu.ac.bd, Rezwan, Rifat¹ (AUTHOR), Singh, Timothy¹ (AUTHOR), Mayesha, Iffat Islam¹ (AUTHOR), Saba, Sayedatus² (AUTHOR), Jamiruddin, Mohd Raeed¹ (AUTHOR)

Publikováno v: PLoS ONE. 9/24/2024, Vol. 19 Issue 9, p1-18. 18p.

Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.

Autor: Finberg JPM; Neuroscience Group, Rappaport Faculty of Medicine, Haifa, Israel. finberg@technion.ac.il.

Publikováno v: Journal of neural transmission (Vienna, Austria : 1996) [J Neural Transm (Vienna)] 2019 Apr; Vol. 126 (4), pp. 433-448. Date of Electronic Publication: 2018 Nov 01.

Sensor Array for Detection of Early Stage Parkinson's Disease before Medication.

Autor: Finberg JPM; Neuroscience Department, Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Schwartz M; Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Jeries R; Department of Chemical Engineering , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Badarny S; Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Nakhleh MK; Department of Chemical Engineering , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Abu Daoud E; Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Ayubkhanov Y; Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Aboud-Hawa M; Department of Chemical Engineering , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Broza YY; Department of Chemical Engineering , Technion - Israel Institute of Technology , Haifa 3200003 , Israel., Haick H; Department of Chemical Engineering , Technion - Israel Institute of Technology , Haifa 3200003 , Israel.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2018 Nov 21; Vol. 9 (11), pp. 2548-2553. Date of Electronic Publication: 2018 Jul 13.